Neuroprotection Therapeutic Market
Neuroprotection Therapeutic Market Analysis, By Product (Free Radical Trapping Agents (Antioxidants), Glutamate Antagonists (Anti-Excitotoxic Agents), Apoptosis Inhibitors, Anti-inflammatory Agents, Neurotrophic Factors (NTFs), Other Products), By Medical Condition (Alzheimer's Disease, Dementia, Epilepsy, Multiple Sclerosis), By Application (Prevention, Treatment), By End User and Region - Market Insights 2025 to 2035
Analysis of Neuroprotection Therapeutic Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Author:
Md Sanaullah
Editor:
Anushree Karale
- FACT7564MR
- 24 Feb 2025
- Healthcare
- 170 Pages
- Tables
- Figures
- Base Value(2024): 70.1 Bn
- Forecast Value (2035): 153.1 Bn
- CAGR (2035): 7.4%
Table of Content
- Executive Summary
- Industry Introduction, including Taxonomy and Market Definition
- Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
- Pricing Analysis
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
- Product
- Medical Condition
- Application
- End User
- By Product
- Free Radical Trapping Agents (Antioxidants)
- Glutamate Antagonists (Anti-Excitotoxic Agents)
- Apoptosis Inhibitors
- Anti-inflammatory Agents
- Neurotrophic Factors (NTFs)
- Other Products
- By Medical Condition
- Alzheimer's Disease
- Dementia
- Epilepsy
- Multiple Sclerosis
- By Application
- Prevention
- Treatment
- By End User
- Hospitals
- Clinics
- Others
- By Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia Pacific
- Middle East & Africa
- North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- South Asia Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Middle East & Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Sales Forecast to 2035 by Product, Medical Condition, Application, and End User for 30 Countries
- Competitive Assessment, Company Share Analysis by Key Players, and Competition Dashboard
- Company Profile
- Allergan PLC
- Daiichi Sankyo Co., Ltd.
- Astrocyte Pharmaceuticals Inc.
- AstraZeneca PLC
- Biogen, Inc.
- Novartis International AG
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
Neuroprotection Therapeutic Market